Ideaya Biosciences Correlations

IDYA Stock  USD 18.39  0.05  0.27%   
The current 90-days correlation between Ideaya Biosciences and Keros Therapeutics is 0.27 (i.e., Modest diversification). The correlation of Ideaya Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Ideaya Biosciences Correlation With Market

Average diversification

The correlation between Ideaya Biosciences and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ideaya Biosciences and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ideaya Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.

Moving together with Ideaya Stock

  0.85CDIOW Cardio DiagnosticsPairCorr
  0.81ELVN Enliven TherapeuticsPairCorr
  0.84SCLX Scilex HoldingPairCorr
  0.9ASMB Assembly Biosciences Earnings Call This WeekPairCorr
  0.72CDIO Cardio DiagnosticsPairCorr
  0.68CMND Clearmind Medicine CommonPairCorr
  0.83CRNX Crinetics PharmaceuticalsPairCorr
  0.64CAT CaterpillarPairCorr
  0.71DIS Walt DisneyPairCorr
  0.86MSFT MicrosoftPairCorr

Moving against Ideaya Stock

  0.85LUCD Lucid DiagnosticsPairCorr
  0.8WM Waste ManagementPairCorr
  0.66GE GE AerospacePairCorr
  0.49PLX Protalix BiotherapeuticsPairCorr
  0.45PG Procter GamblePairCorr
  0.9JNJ Johnson JohnsonPairCorr
  0.85T ATT Inc Earnings Call TomorrowPairCorr
  0.74CVX Chevron CorpPairCorr
  0.68MMM 3M CompanyPairCorr
  0.66XOM Exxon Mobil CorpPairCorr
  0.64IBM International BusinessPairCorr
  0.6CSCO Cisco SystemsPairCorr
  0.6INTC IntelPairCorr
  0.31DD Dupont De NemoursPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
VTYXKROS
VRNAMGTX
VRNAANAB
SNDXVRNA
PTGXMGTX
MGTXANAB
  
High negative correlations   
VRNAVTYX
VRNAKROS
VTYXMGTX
KROSANAB
PTGXVTYX
SNDXPTGX

Risk-Adjusted Indicators

There is a big difference between Ideaya Stock performing well and Ideaya Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ideaya Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANAB  4.32  0.41  0.08  0.23  4.43 
 9.84 
 43.41 
MGTX  3.13  0.40  0.13 (1.29) 3.41 
 5.56 
 34.28 
KROS  2.63 (0.73) 0.00  9.16  0.00 
 4.41 
 19.64 
FIXX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
VTYX  3.35 (0.63) 0.00 (0.46) 0.00 
 6.88 
 27.07 
PTGX  2.79  0.42  0.22 (0.35) 2.47 
 3.48 
 50.66 
VRNA  3.08  0.82  0.26  1.49  2.91 
 7.76 
 17.34 
SNDX  2.39  0.07  0.03  0.02  2.91 
 6.51 
 15.51 
CERE  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
RNA  2.83  0.07  0.00 (0.02) 0.00 
 6.64 
 20.15 

Ideaya Biosciences Corporate Management

Mick OQuigleyChief DevelopmentProfile
Stu DormanChief OfficerProfile
Paul StoneCFO VPProfile
JD EsqChief SecretaryProfile
Matthew MDVP OncologyProfile
Esq JDGen VPProfile
Stuart DormanChief OfficerProfile